Elan announces key appointments

Pharmaceutical giant Elan today announced a number of major appointments to the organisation.

Kelly Martin, president and chief executive officer said the appointments will “demonstrate our successful execution in building a superior organisation”.

Gordon S Francis has joined Elan as vice-president of neurology to provide

scientific, medical, and market expertise in multiple sclerosis (MS).

Tom Kissinger joins Elan as vice president of health care systems for Elan’s Antegren platform.

Paul Logue, hired as vice president, biologics supply, is responsible for the oversight of the new Athlone-based Biologics group and Antegren supply and distribution.

Alan Frost, senior director, Sales and Marketing MS, will provide support to Biogen Idec in setting the global MS launch strategy for Antegren.

Richard Chin, MD will be joining Elan as senior vice president, medical affairs, working with executive vice president and head of therapeutics markets, Juan Carlos Aguilera.

Seamus O’Loan has joined Elan as vice president, business development.